- WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls
- WHO launches iSupport Lite
- WHO discontinues hydroxychloroquine and lopinavir/ritonavir trial arms for COVID-19
- WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
- Statement of the twenty-fifth polio IHR Emergency Committee
- Webinar on Chemicals and COVID Tuesday, 7 July 2020, 11:00 AM-12:30 PM CEST
- Introductory meeting of WHO’s Strategic and Technical Advisory Group for Tuberculosis
- WHO announced as a Global Leader of the Generation Equality Action Coalition on ending gender-based violence
- WHO urges countries to expand access to rapid molecular tests for the detection of TB and drug-resistant TB
- Public call for data on diagnostic accuracy on nucleic acid amplification tests to detect TB and resistance to selected anti-TB agents
- WHO speaks at the European Parliament on the COVID-19 response
- Partners in health: Germany and France commit to increased support to WHO affirming the Organization’s crucial role in global public health
- Timeline of WHO’s response to COVID-19
- 8th TRIAD Meeting: Statement
- Final Statement on the 8th meeting of the International Health Regulations (2005)
OUR ADVERTISERS
